President Pharmacology Declassified Mansfield, New Jersey, United States
Disclosure(s):
Thomas Viola, RPh CCP CDE CPMP: No financial relationships to disclose
Cardiovascular disease and its systemic complications remain the leading cause of death for both men and women and have a significant impact on dental therapy. This program explores the family of cardiovascular diseases (including hypertension, coronary artery disease, hyperlipidemia, and congestive heart failure) and the medications used in their treatment. Participants will explore patient management strategies essential for successful treatment planning. Special emphasis will be given to newly approved anticoagulant agents and their effect on dental therapy.
Fee: October-December: $90 January-February: $130
Learning Objectives:
Identify the different cardiovascular diseases and classes of medications used in their treatment.
Explore the clinical implications of these medications, including adverse reactions and contraindications to dental therapy.
Discuss the newest anticoagulants available, including their adverse reactions and patient care considerations.
.png)
.png)
